[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"transient-neonatal-diabetes-mellitus\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:transient-neonatal-diabetes-mellitus":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":4,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100511909","idmet-radico-cohort-radico-idmet-100511909",false,"NCT05945576","IDMet (RaDiCo Cohort) (RaDiCo-IDMet)","National Cohort on Imprinting Disorders and Their Metabolic Consequences","IDMet","Inclusion Criteria:\n\n* Patients (adults and children) affected with an ID regardless of the severity of the disease\n* A confirmed diagnosis of ID (based on molecular diagnosis)\n* A signed informed consent for adults or signed informed consent of parents\u002Fguardians of minors\u002F protected adult.\n\nNon-Inclusion Criteria:\n\nThere are no non-inclusion criteria.","ALL",{"count":19,"type":20},2000,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to describe the natural history of imprinting disorders (IDs) according to their metabolic profile in all patients (adults and children) affected with an ID regardless of the severity of the disease, with a molecular characterization, with a signed informed consent for all subjects, followed in one partner's center.\n\nThe main questions it aims to answer are:\n\n* Can we identify common metabolic profiles for all imprinted diseases?\n* Which imprinting disorders have an impact on the metabolic profiles of IDs?\n* Which are the metabolic risks associated to IDs?\n* Can we use the metabolic profiles for the clinical classification and prognosis of IDs?\n* Are there common therapeutic approaches for all IDs?",[24,25,26,27,28,29,30,31,32],"Silver Russell Syndrome","Beckwith-Wiedemann Syndrome","Transient Neonatal Diabetes Mellitus","Angelman Syndrome","Prader-Willi Syndrome","Temple Syndrome","Kagami-Ogata Syndrome","Pseudohypoparathyroidism","Familial Precocious Puberty","RECRUITING","2026-02-10",{"date":36,"type":37},"2026-02-12","ACTUAL",{"date":39,"type":37},"2017-03-10",{"date":41,"type":20},"2028-03",{"name":43,"class":44},"Institut National de la Santé Et de la Recherche Médicale, France","OTHER_GOV",20]